Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Aherne

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Haematology and Blood Transfusion|January 1, 1983
The clinical pharmacology of cytosine arabinosideM L Slevin, E M Piall, G W Aherne, et al.
Medical and Pediatric Oncology|January 1, 1982
The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapyM L Slevin, E M Piall, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusionM L Slevin, E M Piall, G W Aherne, et al.
British Journal of Cancer|January 1, 1997
Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapyM P Findlay, D Cunningham, G Morgan, et al.
The Clinical Journal of Pain|June 1, 1989
M6G and its analgesic action in chronic useP J Hoskin, G W Hanks, C W Heron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studiesD C Farrugia, G W Aherne, L Brunton, et al.
British Journal of Cancer|August 23, 2000
Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331S D Webley, A Hardcastle, R D Ladner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cellsC L van der Wilt, K Smid, G W Aherne, et al.
British Journal of Clinical Pharmacology|April 1, 1989
The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteersP J Hoskin, G W Hanks, G W Aherne, et al.
Lancet (London, England)|February 27, 1988
Enterohepatic circulation of morphineG W Hanks, P J Hoskin, G W Aherne, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Haematology and Blood Transfusion|January 1, 1983
The clinical pharmacology of cytosine arabinosideM L Slevin, E M Piall, G W Aherne, et al.
Medical and Pediatric Oncology|January 1, 1982
The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapyM L Slevin, E M Piall, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusionM L Slevin, E M Piall, G W Aherne, et al.
British Journal of Cancer|January 1, 1997
Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapyM P Findlay, D Cunningham, G Morgan, et al.
The Clinical Journal of Pain|June 1, 1989
M6G and its analgesic action in chronic useP J Hoskin, G W Hanks, C W Heron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studiesD C Farrugia, G W Aherne, L Brunton, et al.
British Journal of Cancer|August 23, 2000
Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331S D Webley, A Hardcastle, R D Ladner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cellsC L van der Wilt, K Smid, G W Aherne, et al.
British Journal of Clinical Pharmacology|April 1, 1989
The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteersP J Hoskin, G W Hanks, G W Aherne, et al.
Lancet (London, England)|February 27, 1988
Enterohepatic circulation of morphineG W Hanks, P J Hoskin, G W Aherne, et al.
Pageof 14